NL-OMON35583已完成不适用
Evaluation of the PneumRx, Inc. Lung Volume Reduction Device for the Treatment of Emphysema. - LVR-Coil Safety Study
PneumRx, Inc0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Emphysema on HRCT-thorax
- •Post-bronchodilator FEV1 < 45% predicted
- •Total Lung Capacity > 100% predicted
- •mMRC dyspnea score >2
- •Stopped smoking > 8 weeks
排除标准
- •History of recurrent respiratory infections and/or bronchiectasis
- •Cardiovasculair pathology
- •Inability to walk > 140 meters in 6 minutes
- •Giant bullae (> 1/3 lung volume)
- •Patient is taking > 20 mg prednisone (or similar steroid) daily
- •Patient has evidence of other disease that may compromise survival (such as lung cancer, renal failure etc)
研究者
相似试验
已完成
2 期
Evaluation of the PneumRx, Inc. Lung Volume Reduction Device for the Treatment of Subjects with Homogeneous EmphysemaEmphysemaNL-OMON35800PneumRx10
撤回
不适用
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin DeficiencyAlpha-1-Antitrypsin DeficiencyChronic Obstructive Lung DiseaseEmphysemaNCT02273349University Hospital, Saarland
已完成
不适用
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat EmphysemaEmphysemaNCT01220908Boston Scientific Corporation36
已完成
2 期
Feasibility Study of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of EmphysemaEmphysemaCOPD10038716NL-OMON36664PneumRx, Inc20
已完成
不适用
ung Volume Recruitment in Neuromuscular Disease: Can ‘breath-stacking’ improve lung function, respiratory symptoms and quality of life for people with neuromuscular disease?Spinal cord injuryACTRN12615000565549Institute for Breathing and Sleep80